Abstract
Objectives: To compare the effects of morning and evening dosing of amlodipine on both circadian blood pressure (BP) and heart rate (HR) in mild-to-moderate essential hypertension.
Design: A perspective, double-blind, randomized, crossover design with dose titration.
Patients and methods: Sixty-two patients recruited in the study were aged 21–77 years and had mild-to-moderate essential hypertension. At the end of a 2-week single-blind, placebo run-in period, eligible patients were randomly assigned to morning (7 AM) and evening (9 PM) amlodipine treatment. The initial dose was 5 mg. After 2 weeks of double-blind therapy, patients with a seated diastolic blood pressure ≥90 mm Hg had their doses titrated upward to 10 mg, while the other patients remained on their original 5 mg doses for another 4 weeks period, than crossover to the alternate dosing regimen for 6 additional weeks. The 24-h ambulatory monitoring was performed at baseline and at 6 and 12 weeks after randomization.
Results: 24-h diastolic BP load (11.0 ± 17.5% vs. 6.5 ± 9.1%, P < 0.05) and night-time BP load (28.5 ± 31.4%/17.7 ± 28.2% vs. 20.0 ± 27.9%/9.2 ± 17.8%, P < 0.05/0.05) were significantly greater with evening dosing compared with morning dosing. Nocturnal fall of BP was greater with morning dosing than with evening dosing (9.8 ± 6.7/7.4 ± 5.3 vs. 6.7 ± 6.6/5.4 ± 5.4 mm Hg, P < 0.01/0.05). Percentage of nocturnal BP fall was greater with morning dosing versus with evening dosing (7.9 ± 5.3%/9.6 ± 6.8% vs. 5.4 ± 7.0%/7.0 ± 6.9%, P < 0.01/0.05).
Conclusions: Morning administered amlodipine had a better effect on the circadian BP compared with evening administrated amlodipine in mild-to-moderate essential hypertension.
Similar content being viewed by others
References
Prisant LM. Hypertension and chronotherapy: Shifting the treatment paradigm. Am J Hypertens 2001; 14: 277s-279s.
White WB. A chronotherapeutic approach to the management of hypertension. Am J Hypertens 1996; 10: 29s-32s.
Lemmer B. Differential effects of antihypertensive drugs on circadian rhythm in blood pressure from chronobiologic point of view. Blood Press Monitor 1996; 1: 161-169.
Palatini P,Racioppa A,Raule G,Zaninotto M,Penzo M,Pessina AC. Effect of timing of administration on the plasma ACE inhibitory activity and the antihypertensive effect of quinapril. Clin Pharmacol Ther 1992; 52: 378-383.
Pickering TG,Levenstein M,Walmsley P. Night-time dosing of doxazosin has peak effect on morning ambulatory blood pressure. Results of HALT study. Am J Hypertens 1994; 6: 844-847.
Whelton A,Miller WE,Dunne B Jr,Hait HI,Tresznewsky ON. Once-daily lisinopril compared with twice-daily captopril in the treatment of mild-to-moderate hypertension, assessment of office and ambulatory blood pressure. J Clin Pharmacol 1990; 30: 1074-1080.
Abernathy DA. Pharmacokinetics and pharmacodynamics of amlodipine. Cardiology 1992; 80(Suppl 1): 31-36.
White WB. Methods of blood pressure determination to assure antihypertensive agent: Are causal measurements enough? Clin Pharmacol Ther 1989; 45: 581-586.
Coats AJ,Conway J,Somers VK,Isea JE,Sleight P. Ambulatory blood pressure monitoring in the assessment of antihypertensive therapy. Cardiovasc Drugs Ther 1989; 3: 303-311.
White WB,Mansoor GA,Pickering TG, et al. Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate. Am J Hypertens 1999; 12: 806-814.
White WB. Circadian variation of blood pressure: Clinical relevance and implications for cardiovascular chronotherapeutics. Blood Press Monitor 1997; 2: 47-52.
Lemmer B,Portaluppi F. Chronopharmacology of cardiovascular disease. In: Redfern PH,Lemmer B, eds. Handbook of Experimental Pharmacology, Vol. 125, Berlin: Springer-Verlag, 1997: 251-297.
Morgan T,Anderson A,Jones E. The effect on 24 h blood pressure control of an angiotensin converting enzyme inhibitor (perindopril) administered in the morning or at night. J Hypertens 1997; 15: 205-211.
Witte K,Weisser K,Neubeck M, et al. Cardiovascular effects, pharmacokinetics and converting enzyme inhibition of enalapril after morning versus evening administration. Clin Pharmacol Ther 1993; 54: 177-186.
Greminger P,Suter PM,Holm D,Kobelt R,Vetter W. Morning versus evening administration of nifedipine gastrointestinal therapeutic system in the management of essential hypertension. Clin Invest 1994; 72: 864-869.
White WB,Mansoor GA,Tendler BE,Anwar VA. Nocturnal blood pressure epidemiology, determinant, and effects of antihypertensive therapy. Blood Press Monitor 1998; 3: 43-51.
Verdecchia P,Porcellati C,Schillaci G, et al. Ambulatory blood pressure: An independent predictor of prognosis in essential hypertension. Hypertension 1994; 24: 793-801.
Verdecchia P,Schillaci G,Guerrieri M, et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990; 81: 528-536.
Kuwajima I,Suzuki Y,Shimosawa T,Kanemaru A,Hoshino S,Kuramoto K. Diminished nocturnal decline in blood pressure in elderly hypertensive patients with left ventricular hypertrophy. Am Heart J 1992; 67: 1307-1311.
Rizzoni D,Muiesan ML,Montani G,Zulli R,Calebich S,Agabiti-Rosei E. Relationship between initial cardiovascular structural changes and daytime and night-time blood pressure monitoring. Am J Hypertens 1992; 5: 180-186.
Pierdomenico SD,Lapenna D,Guglielmi MD, et al. Arterial disease in dipper and nondipper hypertensive patients. Am J Hypertens 1997; 10: 511-518.
Ferrara AL,Pasanisi F,Crivaro M, et al. Cardiovascular abnormalities in never-treated hypertensives according to nondiper status. Am J Hypertens 1998; 11: 1352-1357.
Smolensky MH,Haus E. Circadian rhythms and clinical medicine with applications to hypertension. Am J Hypertens 2001; 14: 280s-290s.
Kario K,Matsuo T,Kobayashi H,Imiya M,Matsuo M,Shimada K. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly patients: Advanced silent cerebrovascular damage in extreme dippers. Hypertension 1996; 27: 130-135.
Watanabe N,Imai Y,Nagai K, et al. Nocturnal blood pressure and silent cerebrovascular lesions in elderly Japanese. Stroke 1996; 27: 1319-1327.
White WB,Dey HM,Schulman P. Assessment of the daily blood pressure load as a determinant of cardiac function in patients with mild-to-moderate hypertension. Am Heart J 1989; 118: 782-795.
Sorof JM,Cardwell G,Franco K,Portman RJ. Ambulatory blood pressure and left ventricular mass index in hypertensive children. Hypertension 2002; 39: 903-908.
Levy D,Garrison RJ,Savage DD,Kannel WB,Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-1566.
Casale PN,Devereux RB,Milner M, et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986; 105: 173-178.
Pfeffer M. Clinical implications of left ventricular hypertrophy in systemic hypertension. Cardiovasc Rev Rep Jan 1991: 53-60.
Schillaci G,Verdecchia P,Porcellati C,Cuccurullo O,Cosco C, andPerticone F. Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension 2000; 35: 580-586.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Qiu, YG., Chen, JZ., Zhu, JH. et al. Differential Effects of Morning or Evening Dosing of Amlodipine on Circadian Blood Pressure and Heart Rate. Cardiovasc Drugs Ther 17, 335–341 (2003). https://doi.org/10.1023/A:1027347723347
Issue Date:
DOI: https://doi.org/10.1023/A:1027347723347